Skip to content

The Beauty Health Company SKIN Preferred Stock, Par or Stated Value Per Share

Preferred Stock, Par or Stated Value Per Share at other companies

Solesence, Inc. Common Stock logo
Solesence, Inc. Common StockSLSN
Lifevantage Corporation logo
Lifevantage CorporationLFVN
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
Kenvue logo
KenvueKVUE
Helen Of Troy logo
Helen Of TroyHELE
PROCEPT BioRobotics Corporation logo
PROCEPT BioRobotics CorporationPRCT

Other financials

Income statement

See full
Revenue$64.9M-6.7%
Gross profit$44.4M-8.5%
Operating income-$1.8M+85.0%
Net income-$6.6M+34.3%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$204.4M-45.2%
Total debt$125.9M+756%
Total equity$55.2M+19.9%
Total assets$473.2M-29.8%

Cash flow

See full
Operating cash flow-$5.6M-285%
CapEx$224.0K+398%
Free cash flow-$5.8M-296%

Valuation

See full
Market cap$89.75M-61.5%
Enterprise value$11.24M-96.2%
P/S0.3×-0.4×

Profitability

See full
Gross margin64.9%+8.3pp
Operating margin-3.6%-1.6pp
Net margin-2%-0.9pp
FCF margin9.6%

Returns & leverage

See full
Return on equity-12%-5.4pp
Debt / equity2.3×+2.0×
Current ratio1.8×-5.7×

Where this comes from

Reported directly by The Beauty Health Company in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.

The official record: The Beauty Health Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Beauty Health Company's preferred stock, par or stated value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Beauty Health Company's preferred stock, par or stated value per share?
The Beauty Health Company (SKIN) reported preferred stock, par or stated value per share of $0 in Q1 2026.
How has The Beauty Health Company's preferred stock, par or stated value per share changed year-over-year?
The Beauty Health Company's preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.